The global no radioactive nucleic acid labeling product market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing demand for nucleic acid labeling products in various research and diagnostic applications such as DNA sequencing, RNA sequencing, and protein expression analysis.
The biotin segment accounted for the largest share of the global no radioactive nucleic acid labeling product market in 2017, followed by DIG system and fluorescent segments respectively. The biotin segment is expected to maintain its dominance throughout the forecast period due to its wide range of applications in various research fields such as genomics, proteomics, metabolomics, and epigenetics studies.
Some Of The Growth Factors Of This Market:
- The Non-Radioactive Nucleic Acid Labeling Product market is driven by the increasing demand for nucleic acid labeling products in the pharmaceutical and biotechnology industries.
- The Non-Radioactive Nucleic Acid Labeling Product market is also driven by the increasing demand for nucleic acid labeling products in research laboratories, hospitals, and academic institutions.
- Increasing number of mergers and acquisitions in the pharmaceutical industry will lead to an increase in R&D expenditure which will drive growth of the Non-Radioactive Nucleic Acid Labeling Product market.
- Increasing government funding for research activities will also drive growth of the Non-Radioactive Nucleic Acid Labeling Product market.
Industry Growth Insights published a new data on “Non-Radioactive Nucleic Acid Labeling Product Market”. The research report is titled “Non-Radioactive Nucleic Acid Labeling Product Market research by Types (Biotin, DIG System, Fluorescent, Others), By Applications (DNA Labeling, RNA Labeling, Oligonucleotide Labeling), By Players/Companies Thermo Fisher Scientific, Roche, Promega, PerkinElmer, Agilent Technologies, General Electric, Enzo Biochem, Merck KGaA, Vector Labs, New England Biolabs”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-Radioactive Nucleic Acid Labeling Product Market Research Report
By Type
Biotin, DIG System, Fluorescent, Others
By Application
DNA Labeling, RNA Labeling, Oligonucleotide Labeling
By Companies
Thermo Fisher Scientific, Roche, Promega, PerkinElmer, Agilent Technologies, General Electric, Enzo Biochem, Merck KGaA, Vector Labs, New England Biolabs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Non-Radioactive Nucleic Acid Labeling Product Market Report Segments:
The global Non-Radioactive Nucleic Acid Labeling Product market is segmented on the basis of:
Types
Biotin, DIG System, Fluorescent, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
DNA Labeling, RNA Labeling, Oligonucleotide Labeling
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Roche
- Promega
- PerkinElmer
- Agilent Technologies
- General Electric
- Enzo Biochem
- Merck KGaA
- Vector Labs
- New England Biolabs
Highlights of The Non-Radioactive Nucleic Acid Labeling Product Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biotin
- DIG System
- Fluorescent
- Others
- By Application:
- DNA Labeling
- RNA Labeling
- Oligonucleotide Labeling
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-Radioactive Nucleic Acid Labeling Product Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non-radioactive nucleic acid labeling products are used to identify and track the movement of genetic materials. These products can be used in a variety of research settings, including genomics, proteomics and pharmacology.
Some of the major players in the non-radioactive nucleic acid labeling product market are Thermo Fisher Scientific, Roche, Promega, PerkinElmer, Agilent Technologies, General Electric, Enzo Biochem, Merck KGaA, Vector Labs, New England Biolabs.
The non-radioactive nucleic acid labeling product market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non-Radioactive Nucleic Acid Labeling Product Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Non-Radioactive Nucleic Acid Labeling Product Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Non-Radioactive Nucleic Acid Labeling Product Market - Supply Chain
4.5. Global Non-Radioactive Nucleic Acid Labeling Product Market Forecast
4.5.1. Non-Radioactive Nucleic Acid Labeling Product Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Non-Radioactive Nucleic Acid Labeling Product Market Size (000 Units) and Y-o-Y Growth
4.5.3. Non-Radioactive Nucleic Acid Labeling Product Market Absolute $ Opportunity
5. Global Non-Radioactive Nucleic Acid Labeling Product Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Type
5.3.1. Biotin
5.3.2. DIG System
5.3.3. Fluorescent
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Non-Radioactive Nucleic Acid Labeling Product Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Application
6.3.1. DNA Labeling
6.3.2. RNA Labeling
6.3.3. Oligonucleotide Labeling
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Non-Radioactive Nucleic Acid Labeling Product Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Non-Radioactive Nucleic Acid Labeling Product Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Non-Radioactive Nucleic Acid Labeling Product Demand Share Forecast, 2019-2026
9. North America Non-Radioactive Nucleic Acid Labeling Product Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Application
9.4.1. DNA Labeling
9.4.2. RNA Labeling
9.4.3. Oligonucleotide Labeling
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Type
9.7.1. Biotin
9.7.2. DIG System
9.7.3. Fluorescent
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Non-Radioactive Nucleic Acid Labeling Product Demand Share Forecast, 2019-2026
10. Latin America Non-Radioactive Nucleic Acid Labeling Product Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Application
10.4.1. DNA Labeling
10.4.2. RNA Labeling
10.4.3. Oligonucleotide Labeling
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Type
10.7.1. Biotin
10.7.2. DIG System
10.7.3. Fluorescent
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Non-Radioactive Nucleic Acid Labeling Product Demand Share Forecast, 2019-2026
11. Europe Non-Radioactive Nucleic Acid Labeling Product Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Application
11.4.1. DNA Labeling
11.4.2. RNA Labeling
11.4.3. Oligonucleotide Labeling
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Non-Radioactive Nucleic Acid Labeling Produt Market Size and Volume Forecast by Type
11.7.1. Biotin
11.7.2. DIG System
11.7.3. Fluorescent
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Non-Radioactive Nucleic Acid Labeling Product Demand Share, 2019-2026
12. Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Application
12.4.1. DNA Labeling
12.4.2. RNA Labeling
12.4.3. Oligonucleotide Labeling
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Type
12.7.1. Biotin
12.7.2. DIG System
12.7.3. Fluorescent
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Demand Share, 2019-2026
13. Middle East & Africa Non-Radioactive Nucleic Acid Labeling Product Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Application
13.4.1. DNA Labeling
13.4.2. RNA Labeling
13.4.3. Oligonucleotide Labeling
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Non-Radioactive Nucleic Acid Labeling Product Market Size and Volume Forecast by Type
13.7.1. Biotin
13.7.2. DIG System
13.7.3. Fluorescent
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Non-Radioactive Nucleic Acid Labeling Product Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Non-Radioactive Nucleic Acid Labeling Product Market: Market Share Analysis
14.2. Non-Radioactive Nucleic Acid Labeling Product Distributors and Customers
14.3. Non-Radioactive Nucleic Acid Labeling Product Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Promega
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. PerkinElmer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Agilent Technologies
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. General Electric
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Enzo Biochem
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Merck KGaA
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Vector Labs
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. New England Biolabs
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
